Healthcare
•3753 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3753)
| Company | Market Cap | Price |
|---|---|---|
|
CATX
Perspective Therapeutics, Inc.
Company directly develops and provides radiopharmaceuticals using alpha-emitting Lead-212 for targeted cancer therapy and diagnostic imaging via 203Pb in a theranostic approach.
|
$173.03M |
$2.34
-5.65%
|
|
SRZN
Surrozen, Inc.
Direct ophthalmic drug development focusing on retinal diseases using Wnt-modulating antibodies.
|
$171.41M |
$20.00
|
|
PEPG
PepGen Inc.
PepGen's PGN-EDODM1 is an oligonucleotide therapeutic targeting DM1, aligning directly with Oligonucleotide Therapeutics.
|
$170.56M |
$5.21
+4.51%
|
|
ARCT
Arcturus Therapeutics Holdings Inc.
Direct product: vaccines pipeline and KOSTAIVE vaccine production and commercialization.
|
$169.72M |
$6.21
+1.22%
|
|
INGN
Inogen, Inc.
Company manufactures medical devices and respiratory care equipment (POCs, SOCs, Simeox), a core medical devices business.
|
$169.00M |
$6.25
-3.10%
|
|
NTHI
Neonc Technologies Holdings, Inc.
Directly produces oncology-focused biotech therapies; lead programs NEO100/NEO212 targeting brain cancers.
|
$167.26M |
$8.82
+1.38%
|
|
TMCI
Treace Medical Concepts, Inc.
Treace's core bunion correction systems are surgical instruments/devices used in operative procedures.
|
$166.78M |
$2.65
-0.19%
|
|
IMRX
Immuneering Corporation
Atebimetinib (IMM-1-104) is an oral small-molecule therapeutic in clinical trials.
|
$166.34M |
$4.58
-1.29%
|
|
ACU
Acme United Corporation
SmartCompliance RFID First Aid kits indicate the company produces medical devices & biometrics-enabled safety products.
|
$165.99M |
$43.84
-0.17%
|
|
MXCT
MaxCyte, Inc.
ExPERT medical device platform for cell engineering and its related consumables constitute MaxCyte's core product offerings in healthcare hardware.
|
$164.17M |
$1.55
+0.65%
|
|
VXRT
Vaxart, Inc.
VXRT directly develops and advances vaccines (norovirus, COVID-19, avian influenza) using its VAAST oral vaccine platform.
|
$159.95M |
$0.70
|
|
CCCC
C4 Therapeutics, Inc.
Lead assets (e.g., cemsidomide) are orally bioavailable small-molecule degraders, fitting the 'Oral Small Molecule Therapeutics' category.
|
$158.71M |
$2.25
+1.13%
|
|
CYDY
CytoDyn Inc.
Leronlimab is a monoclonal antibody therapeutic, aligning CytoDyn with Monoclonal Antibody Therapeutics.
|
$158.28M |
$0.26
|
|
MOLN
Molecular Partners AG
Core focus on oncology therapeutics built on the DARPin platform.
|
$157.05M |
$4.20
-1.87%
|
|
RELL
Richardson Electronics, Ltd.
Medical devices and equipment manufacturing including CT X-ray tubes and related products remain part of the portfolio.
|
$156.38M |
$10.80
-0.28%
|
|
THTX
Theratechnologies Inc.
EGRIFTA WR and TH1902 are peptide-based therapeutics, representing Theratechnologies' core peptide therapeutics business.
|
$155.87M |
$3.39
|
|
ACNT
Ascent Industries Co.
Custom manufacturing / contract manufacturing services.
|
$154.20M |
$16.44
-1.91%
|
|
SAVA
Cassava Sciences, Inc.
Direct product category: simufilam is developed as an oral small-molecule therapeutic.
|
$154.10M |
$3.23
+1.10%
|
|
QIPT
Quipt Home Medical Corp.
Quipt designs/markets medical devices and biometric sensing technology used in home respiratory care and diabetes monitoring (CGMs).
|
$153.36M |
$3.54
+0.14%
|
|
JYNT
The Joint Corp.
The Joint operates chiropractic clinics delivering hands-on care, representing a healthcare services & facilities business.
|
$152.36M |
$9.94
-5.65%
|
|
AIRS
AirSculpt Technologies, Inc.
AirSculpt provides premium, minimally invasive body contouring services through a network of centers, i.e., healthcare services and facilities.
|
$151.72M |
$2.44
+9.91%
|
|
EDAP
Edap Tms S.a.
Focal One is a robotic surgical energy delivery device used for focal therapy of urological cancers.
|
$151.05M |
$4.03
-1.47%
|
|
CDXS
Codexis, Inc.
Codexis is pivoting to manufacturing RNAi therapeutics using the ECO Synthesis platform, directly targeting RNAi drug production.
|
$150.75M |
$1.68
-5.62%
|
|
TNXP
Tonix Pharmaceuticals Holding Corp.
TNX-102 SL is Tonix's lead oral small-molecule drug for fibromyalgia (cyclobenzaprine HCl sublingual), a direct product the company develops and plans to bring to market.
|
$150.25M |
$17.13
+7.74%
|
|
RCMT
RCM Technologies, Inc.
RCMT's offerings align with Healthcare Services & Facilities through its healthcare staffing/model and service delivery to care institutions.
|
$149.40M |
$20.20
-1.89%
|
|
APYX
Apyx Medical Corporation
APYX designs and sells medical devices (Renuvion helium plasma platform and AYON body contouring system) used in surgical procedures.
|
$149.01M |
$4.00
-0.62%
|
|
GANX
Gain Therapeutics, Inc.
GT-02287 is a small-molecule therapeutic candidate, aligning with the major product category of oral small-molecule therapeutics.
|
$148.83M |
$4.01
-3.02%
|
|
IPHA
Innate Pharma S.A.
Innate Pharma focuses on oncology therapies, including antibody-based approaches, making Biotech - Oncology a core business area.
|
$146.12M |
$1.75
-0.85%
|
Showing page 23 of 38 (3753 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
